ALNYLAM PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.12 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-30
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 1.12M shares, a 89.89% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.79M shares, a 84.80% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 11.08M shares.
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 11.66M shares, a 18.50% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.36M shares, a 70.58% decline from fiscal 2024.
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 11.43M shares, a 12.71% decline from fiscal 2023.
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 13.10M shares, a 3.19% decline from fiscal 2022.
- ALNYLAM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 13.53M shares, a 20.51% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1.12M shares 10-Q · filed 2026-07-30 | 640.00K shares 10-Q · filed 2026-07-30 | ||||
| 2025-12-31 | 3.36M shares 10-K · filed 2026-02-12 | |||||
| 2025-09-30 | 1.79M shares 10-Q · filed 2025-10-30 | 3.65M shares 10-Q · filed 2025-10-30 | ||||
| 2025-06-30 | 11.08M shares 10-Q · filed 2026-07-30 | 11.08M shares 10-Q · filed 2026-07-30 | 11.04M shares 10-Q · filed 2025-07-31 | |||
| 2025-03-31 | 11.66M shares 10-Q · filed 2025-05-01 | |||||
| 2024-12-31 | 11.43M shares 10-K · filed 2026-02-12 | |||||
| 2024-09-30 | 11.78M shares 10-Q · filed 2025-10-30 | 11.78M shares 10-Q · filed 2025-10-30 | ||||
| 2024-06-30 | 12.72M shares 10-Q · filed 2025-07-31 | |||||
| 2024-03-31 | 14.30M shares 10-Q · filed 2025-05-01 | |||||
| 2023-12-31 | 13.10M shares 10-K · filed 2026-02-12 | |||||
| 2023-09-30 | 1.30M shares 10-Q · filed 2023-11-02 | 1.30M shares 10-Q · filed 2024-10-31 | 13.33M shares 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | 13.94M shares 10-Q · filed 2024-08-01 | |||||
| 2023-03-31 | 14.59M shares 10-Q · filed 2024-05-02 | |||||
| 2022-12-31 | 13.53M shares 10-K · filed 2025-02-13 | |||||
| 2022-09-30 | 15.97M shares 10-Q · filed 2023-11-02 | 15.97M shares 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | 14.67M shares 10-Q · filed 2023-08-03 | |||||
| 2022-03-31 | 14.70M shares 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | 11.22M shares 10-K · filed 2024-02-15 | |||||
| 2021-09-30 | 12.96M shares 10-Q · filed 2022-10-27 | |||||
| 2021-06-30 | 13.81M shares 10-Q · filed 2022-07-28 | |||||
| 2021-03-31 | 15.40M shares 10-Q · filed 2022-04-28 | |||||
| 2020-12-31 | 12.85M shares 10-K · filed 2023-02-23 | |||||
| 2020-09-30 | 13.00M shares 10-Q · filed 2021-10-28 | |||||
| 2020-06-30 | 13.63M shares 10-Q · filed 2021-08-03 | |||||
| 2020-03-31 | 15.02M shares 10-Q · filed 2021-04-29 | |||||
| 2019-12-31 | 13.82M shares 10-K · filed 2022-02-10 | |||||
| 2019-09-30 | 14.34M shares 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | 14.47M shares 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | 14.59M shares 10-Q · filed 2020-05-06 | |||||
| 2018-12-31 | 12.61M shares 10-K · filed 2021-02-11 | |||||
| 2018-09-30 | 12.69M shares 10-Q · filed 2019-10-31 | |||||
| 2018-06-30 | 12.94M shares 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | 12.67M shares 10-Q · filed 2019-05-02 | |||||
| 2017-12-31 | 11.39M shares 10-K · filed 2020-02-13 | |||||
| 2017-09-30 | 12.06M shares 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | 12.54M shares 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | 12.21M shares 10-Q · filed 2018-05-04 | |||||
| 2016-12-31 | 12.44M shares 10-K · filed 2019-02-14 | |||||
| 2016-09-30 | 10.90M shares 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | 10.56M shares 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | 10.37M shares 10-Q · filed 2017-05-05 | |||||
| 2015-12-31 | 9.98M shares 10-K · filed 2018-02-15 | |||||
| 2015-09-30 | 8.44M shares 10-Q · filed 2016-11-03 | |||||
| 2015-06-30 | 8.52M shares 10-Q · filed 2016-08-04 | |||||
| 2015-03-31 | 7.80M shares 10-Q · filed 2016-05-04 | |||||
| 2014-12-31 | 8.20M shares 10-K · filed 2017-02-15 | |||||
| 2014-09-30 | 8.11M shares 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | 8.06M shares 10-Q · filed 2015-08-07 | |||||
| 2014-03-31 | 8.57M shares 10-Q · filed 2015-05-08 | |||||
| 2013-12-31 | 9.21M shares 10-K · filed 2016-02-12 | |||||
| 2013-09-30 | 8.61M shares 10-Q · filed 2013-11-07 | 8.61M shares 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | 9.17M shares 10-Q · filed 2013-08-09 | 9.17M shares 10-Q · filed 2014-08-08 | ||||
| 2013-03-31 | 9.17M shares 10-Q · filed 2014-05-09 | |||||
| 2012-12-31 | 9.54M shares 10-K · filed 2015-02-13 | |||||
| 2012-09-30 | 8.79M shares 10-Q · filed 2013-11-07 | 8.79M shares 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | 9.24M shares 10-Q · filed 2013-08-09 | 9.24M shares 10-Q · filed 2013-08-09 | ||||
| 2012-03-31 | 9.74M shares 10-Q · filed 2013-05-07 | |||||
| 2011-12-31 | 10.09M shares 10-K · filed 2014-02-20 | |||||
| 2011-09-30 | 9.16M shares 10-Q · filed 2012-11-05 | 9.16M shares 10-Q · filed 2012-11-05 | ||||
| 2011-06-30 | 9.27M shares 10-Q · filed 2012-08-08 | 9.27M shares 10-Q · filed 2012-08-08 | ||||
| 2010-12-31 | 9.09M shares 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |